Scroll Back to Top

Molecular Tumor Board: 65 year-old female s/p surgery and Stage III high grade ovarian cancer, BRCA1 mutation

December 11, 2023

This Molecular Tumor Board presents a case of a patient with advanced stage high grade serous ovarian cancer whose OmniSeq INSIGHT testing revealed a BRCA1 mutation. Join us as we discuss next diagnostic steps, homologous recombination deficiency and treatment implications. 

Presented by:

Rebecca A. Previs, MD; Director of Medical Affairs

Kyle C. Strickland, MD, PhD; Director of Medical Affairs

Tripti Paudyal, MS, CGC; Medical Science Liaison